Asked by: Lord Gascoigne (Conservative - Life peer)
Question to the Home Office:
To ask His Majesty's Government, in regard to the project titled 'cortical and subcortical control of movement' in Non-technical summaries for project licences granted under the Animals (Scientific Procedures) Act between January to March 2025 that require a retrospective assessment, published on 11 June, what assessment they have made of the expectation that over 95 per cent of non-human primates will experience some infection as a result of long-term implants used for purposes such as head fixation.
Answered by Lord Hanson of Flint - Minister of State (Home Office)
Each application to use animals in science is subject to a harm benefit assessment by a trained Home Office Inspector whom is a member of either the veterinary or medical profession. This ensures that any harm that may be caused to the animals is justified by the expected benefits for humans, animals or the environment.
All applications must conform with all legal requirements set out in the Animals (Scientific Procedures) Act 1986. This includes, applying the principles of the 3Rs (Replacement, Reduction and Refinement); the replacement of animals with alternatives, the reduction of the number of animals used to the minimum possible and the refinement of any techniques to reduce the harm suffered by the animals to the minimum. The Home Office only allows the use of animals if it can be demonstrated that the benefits outweigh the harms and the 3Rs have been fully applied. All licence holders have a responsibility to fully implement the 3Rs and demonstrate this requirement at audit.
Licence holders are also required to complete retrospective assessments for licences if the protocols in the studies are severe. Retrospective assessments must consider whether any lessons can be learnt from the programme of work which may contribute to the further implementation of the principles of replacement, reduction and refinement.
The Department for Science, Innovation & Technology (DSIT) is engaging with stakeholders to finalise a strategy to accelerate the development, validation and uptake of alternatives to animal testing which is scheduled for publication later this year.
Asked by: Lord Gascoigne (Conservative - Life peer)
Question to the Home Office:
To ask His Majesty's Government, in regard to Non-technical summaries for project licences granted under the Animals (Scientific Procedures) Act between January to March 2025 that require a retrospective assessment, published on 11 June, what assessment they have made of the practice of implanting electrodes in the reward centres of brains of non-human primates to motivate them to perform behavioural tasks.
Answered by Lord Hanson of Flint - Minister of State (Home Office)
Each application to use animals in science is subject to a harm benefit assessment by a trained Home Office Inspector whom is a member of either the veterinary or medical profession. This ensures that any harm that may be caused to the animals is justified by the expected benefits for humans, animals or the environment.
All applications must conform with all legal requirements set out in the Animals (Scientific Procedures) Act 1986. This includes, applying the principles of the 3Rs (Replacement, Reduction and Refinement); the replacement of animals with alternatives, the reduction of the number of animals used to the minimum possible and the refinement of any techniques to reduce the harm suffered by the animals to the minimum. The Home Office only allows the use of animals if it can be demonstrated that the benefits outweigh the harms and the 3Rs have been fully applied. All licence holders have a responsibility to fully implement the 3Rs and demonstrate this requirement at audit.
Licence holders are also required to complete retrospective assessments for licences if the protocols in the studies are severe. Retrospective assessments must consider whether any lessons can be learnt from the programme of work which may contribute to the further implementation of the principles of replacement, reduction and refinement.
The Department for Science, Innovation & Technology (DSIT) is engaging with stakeholders to finalise a strategy to accelerate the development, validation and uptake of alternatives to animal testing which is scheduled for publication later this year.